These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21300303)

  • 1. The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training.
    Seljeflot I; Nilsson BB; Westheim AS; Bratseth V; Arnesen H
    J Card Fail; 2011 Feb; 17(2):135-42. PubMed ID: 21300303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric dimethylarginine predicts clinical outcomes in ischemic chronic heart failure.
    Hsu CP; Lin SJ; Chung MY; Lu TM
    Atherosclerosis; 2012 Dec; 225(2):504-10. PubMed ID: 23092827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
    Anderssohn M; Rosenberg M; Schwedhelm E; Zugck C; Lutz M; Lüneburg N; Frey N; Böger RH
    J Card Fail; 2012 Dec; 18(12):904-11. PubMed ID: 23207078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure.
    Dückelmann C; Mittermayer F; Haider DG; Altenberger J; Wolzt M
    Transl Res; 2008 Jul; 152(1):24-30. PubMed ID: 18593634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure.
    Nilsson BB; Westheim A; Risberg MA; Arnesen H; Seljeflot I
    Scand Cardiovasc J; 2010 Aug; 44(4):223-9. PubMed ID: 20636229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure.
    Dückelmann C; Mittermayer F; Haider DG; Altenberger J; Eichinger J; Wolzt M
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):2037-42. PubMed ID: 17569878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol.
    von Haehling S; Bode-Böger SM; Martens-Lobenhoffer J; Rauchhaus M; Schefold JC; Genth-Zotz S; Karhausen T; Cicoira M; Anker SD; Doehner W
    Clin Pharmacol Ther; 2010 Oct; 88(4):506-12. PubMed ID: 20827268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
    Dimitroulas T; Giannakoulas G; Papadopoulou K; Karvounis H; Dimitroula H; Koliakos G; Karamitsos T; Parcharidou D; Settas L
    J Rheumatol; 2010 May; 37(5):993-9. PubMed ID: 20194451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 10-Week Supervised Moderate-Intensity Intermittent vs. Continuous Aerobic Exercise Programs on Vascular Adhesion Molecules in Patients with Heart Failure.
    Aksoy S; Findikoglu G; Ardic F; Rota S; Dursunoglu D
    Am J Phys Med Rehabil; 2015 Oct; 94(10 Suppl 1):898-911. PubMed ID: 25888664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure.
    Young JM; Strey CH; George PM; Florkowski CM; Sies CW; Frampton CM; Scott RS
    Eur J Heart Fail; 2008 May; 10(5):463-6. PubMed ID: 18430606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.
    Tutarel O; Denecke A; Bode-Böger SM; Martens-Lobenhoffer J; Lovric S; Bauersachs J; Schieffer B; Westhoff-Bleck M; Kielstein JT
    PLoS One; 2012; 7(3):e33795. PubMed ID: 22470476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function.
    Erbs S; Höllriegel R; Linke A; Beck EB; Adams V; Gielen S; Möbius-Winkler S; Sandri M; Kränkel N; Hambrecht R; Schuler G
    Circ Heart Fail; 2010 Jul; 3(4):486-94. PubMed ID: 20430934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.
    Berent R; von Duvillard SP; Crouse SF; Auer J; Green JS; Sinzinger H; Schmid P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):603-8. PubMed ID: 19494782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance of arginine and asymmetric dimethylarginine is associated with markers of circulatory failure, organ failure and mortality in shock patients.
    Visser M; Vermeulen MA; Richir MC; Teerlink T; Houdijk AP; Kostense PJ; Wisselink W; de Mol BA; van Leeuwen PA; Oudemans-van Straaten HM
    Br J Nutr; 2012 May; 107(10):1458-65. PubMed ID: 22129964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
    Mommersteeg PM; Schoemaker RG; Eisel UL; Garrelds IM; Schalkwijk CG; Kop WJ
    Psychosom Med; 2015 Apr; 77(3):292-302. PubMed ID: 25790241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM; Beckers P; Vaes J; Martin M; Van Hoof V; De Maeyer C; Possemiers N; Wuyts FL; Vrints CJ
    Eur Heart J; 2004 Oct; 25(20):1797-805. PubMed ID: 15474694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study.
    Thakkar V; Stevens W; Prior D; Rabusa C; Sahhar J; Walker JG; Roddy J; Lester S; Rischmueller M; Zochling J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):129-136. PubMed ID: 27214686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.